Talk #3 in Plenary III - "Involucrin Deficiency results in Decreased Vitamin D Receptor‐Mediated Inflammation and Csnk1e Isoform Bias" from the lab of @cdgstrong21 at @WashUDerm#sid2021 1/n
Involucrin is a major scaffolding protein in the epidermis, and the @cdgstrong21 lab recently discovered that there is a positive selection pressure for increased involucrin expression out-of-Africa - this is work that is in press @sid2021 2/n
Interesting that involucrin knockout mice develop a normal skin barrier - but the role of involucrin for skin homeostasis is not known. To determine the response, a well known vitD agonist model of cutaneous inflammation was applied to involucrin knockout mice #sid2021 3/n
drumroll... involucrin knockout mice develop less ear thickness in response to vitD agonist, what can explain this reduced inflammatory response? CD4+ T cells and TSLP receptor expression was reduced in the involucrin knockouts, explaining the reduced response #sid2021 4/n
Digging in deeper, they sought to determine if involucrin knockout mice had differentially accessible chromatin regions (by ATAC-seq), differentially expressed genes (by RNA-seq) or differentially expressed proteins (by LC/MS). 5/n #SID2021
Csnk1e (Casein Kinase 1), a gene related to circadian rhythms, was found to have differentially accessible chromatin regions and differentially (lower) expressed levels of protein. 6/n #sid2021
Bringing back to human evolution - they show that as skin pigmentation increases, involucrin and vitamin D receptor expression both decreases by similar amounts. There appears to be a conserved dosage relationship between these two. 7/n #SID2021
A question after the talk - what is the role of circadian rhythm in the skin? @cdgstrong21 lab's hypothesis is that variation in involucrin and csnk1 levels may reflect longer vs shorter duration circadian rhythms at different latitudes, but more study is needed! 8/8 #sid2021
• • •
Missing some Tweet in this thread? You can try to
force a refresh
First State of the Art Lecture on Thursday was Isaac Brownell from the Dermatology Branch at @NIH_NIAMS, in a talk titled "Merkel cells and Merkel cell carcinoma: neuroendocrine skin cells from development to cancer" 1/n #sid2021
Merkel cells are innervated neuroendocrine cells, and they function as mechanical sensors. In mouse skin they actually cluster around specialized keratinocytes that are part of structure call the 'touch dome' 2/n #sid 2021
It turns out that sonic hedgehog signaling from sensory nerves is required to maintain that touch dome - this is a deep connection between the nervous system and keratinocytes 3/n #sid2021
Last talk of Plenary III comes from @KYTsaiLab, titled "Topical MEK Inhibition as Precision Targeted Chemoprevention". Like the 1st talk by @CarolynLeeMDPhD, this talk is focused on cutaneous squamous cell carcinoma 1/n #SID2021
In prior work (nature.com/articles/ncomm…) this group found that MEK inhibition could help prevent progression of lesions from premalignant actinic keratosis to cutaneous SCC #sid2021 2/n
They use a hairless mouse UV-driven cutaneous SCC model for preclinical testing, and found that systemic MEK inhibition prevented skin cancer lesions. To avoid systemic side effects thought, they developed a topical MEK inhibitor gel #sid2021 3/n
Talk #2 from Plenary III is from @NUFeinbergDerm, José-Marc Techner, presenting "Oral Vitamin D3 reduces chemical-induced skin inflammation in humans" #SID2021 1/n
The focus of this work is to understand the mechanisms of chemical-induced skin inflammation, and to unravel how systemic vitamin D3 can suppress the deep dermal inflammatory response. @SID2021 2/n
The investigators designed a double blinded RCT - 28 healthy volunteers had 2 exposures to topical nitrogen mustard, half got vitamin D3 and half got placebo at the 2nd nitrogen mustard exposure, and labs, skin biopsy, and skin redness was measured throughout 3/n #sid2021
In Plenary III, @CarolynLeeMDPhD starts off with "Somatic Mutation of the OXA1L 5’UTR enables Cutaneous Squamous Cell Carcinoma". Skin cancer is the most common malignancy, and rates of SCC may be similar to BCC, 100k SCC metastasize annually with limited tx options. #SID2021 1/
Surgery is standard of care for SCC, but for many patients surgery is not an option and Dr. Lee sought to determine actionable genetic alterations in SCC to inspire targeted non-surgical treatment options #SID2021 2/n
In previous work, Dr. Lee and colleagues performed sequencing of SCC (pubmed.ncbi.nlm.nih.gov/25194279/) and did not find clear tumor driving mutations #SID2021 3/n
"Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune checkpoint inhibitors: A United States population-level analysis" by @EugeneSemenovMD
Immune checkpoint inhibitors have improved survival across multiple cancers. However, they can cause cutaneous immune-related adverse events (irAEs). >40 cutaneous eruptions have been associated with ICIs, including immunobullous, lichenoid dermatitis, & psoriasiform. #SID2021
They performed an observational study comparing patients on ICIs to matched controls. They found the overall incidence of immune-related adverse events to be 25% in the real world, lower than estimates in clinical trials. #SID2021